piribedil has been researched along with ergoline in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (86.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costall, B; Naylor, RJ | 1 |
| Hungerbühler, JP; Regli, F | 1 |
| Breese, GR; Mailman, RB; Mueller, RA | 1 |
| Parkes, JD | 1 |
| Juorio, AV | 1 |
| Anlezark, GM; Meldrum, BS | 1 |
| Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE | 1 |
| Handforth, A; Sourkes, TL | 1 |
| Chagraoui, A; Protais, P; Vasse, M | 1 |
| Agid, Y; Dubois, B | 1 |
| Burton, K; Calne, DB | 1 |
| Gianutsos, G; Moore, KE | 1 |
| Krulich, L; Mayfield, MA; McCann, SM | 1 |
| Gekht, AB | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
4 review(s) available for piribedil and ergoline
| Article | Year |
|---|---|
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
Bromocriptine in the treatment of parkinsonism.
Topics: Apomorphine; Bromocriptine; Catecholamines; Drug Interactions; Ergolines; Humans; Kinetics; Motor Activity; Movement Disorders; Parkinson Disease; Piribedil; Receptors, Drug; Stereotyped Behavior | 1979 |
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
11 other study(ies) available for piribedil and ergoline
| Article | Year |
|---|---|
Apomorphine as an antagonist of the dopamine response from the nucleus accumbens.
Topics: Animals; Apomorphine; Dextroamphetamine; Dopamine; Dopamine Antagonists; Ergolines; Injections, Intraventricular; Male; Motor Activity; Piribedil; Rats; Stimulation, Chemical | 1976 |
Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
Topics: Animals; Antipsychotic Agents; Apomorphine; Cerebellum; Corpus Striatum; Cyclic AMP; Cyclic GMP; Dopamine; Dopamine Antagonists; Drug Interactions; Ergolines; Hydroxydopamines; Motor Activity; Paralysis; Piribedil; Rats | 1979 |
Drug-induced changes in the formation, storage and metabolism of tyramine in the mouse.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Apomorphine; Clorgyline; Corpus Striatum; Ergolines; Male; Methyltyrosines; Mice; Piribedil; Reserpine; Tetrabenazine; Tranylcypromine; Tyramine | 1979 |
Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice.
Topics: Acoustic Stimulation; Animals; Apomorphine; Ergolines; Exploratory Behavior; Male; Mice; Mice, Inbred DBA; Motor Activity; Piperazines; Piribedil; Receptors, Drug; Seizures | 1975 |
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil | 1975 |
Inhibition by dopamine agonists of dopamine accumulation following gamma-hydroxybutyrate treatment.
Topics: Animals; Apomorphine; Brain; Bromocriptine; Codeine; Depression, Chemical; Dopamine; Ergolines; Haloperidol; Hydroxybutyrates; Male; Naphthols; Piribedil; Rats | 1975 |
Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Appetite Depressants; Behavior, Animal; Benzazepines; Bromocriptine; Ergolines; Male; Mice; Mice, Inbred Strains; Piribedil; Quinpirole; Receptors, Dopamine; Stereotyped Behavior | 1988 |
[Dopaminergic agonists in Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil | 1986 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Differential behavioral and biochemical effects of four dopaminergic agonists.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Bromocriptine; Dopamine; Ergolines; Haloperidol; Male; Methyltyrosines; Mice; Motor Skills; Piribedil | 1980 |
On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
Topics: Animals; Cyproheptadine; Dose-Response Relationship, Drug; Ergolines; Flupenthixol; Hypothalamus; Kinetics; Male; Median Eminence; Metergoline; Methysergide; Piribedil; Prolactin; Rats; Receptors, Serotonin | 1981 |